Fig 3. Annual relative survival amongst cardiac surgery patients surviving the first 30 postoperative days.
A) Shown in total (n = 8,380) and separately for males (n = 6,244) and females (n = 2,136). B) Shown for patients undergoing isolated coronary artery bypass grafting (CABG, n = 5,593), isolated aortic valve replacement (AVR, n = 699) and combined CABG and AVR (n = 809). A relative survival >1 indicates a survival advantage in the study cohort.